← Back to Search

Other

Air Filtration for COPD

N/A

Recruiting

Led By Mohammad Heidarinejad, PhD

Research Sponsored by Illinois Institute of Technology

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will investigate if air filters can improve air quality & COPD outcomes for veterans in high-risk urban settings. It'll also look at housing factors, sensors & costs/benefits.

Who is the study for?

This trial is for U.S. military veterans aged 18 and older who have COPD, live in Chicago, can consent, speak English, have stable housing for over 6 months, can communicate by phone, are fully vaccinated against COVID-19 and receive care at JBVAMC. Those with a life expectancy under 6 months or hazardous home conditions cannot join.Check my eligibility

What is being tested?

The study tests if stand-alone air filters improve indoor air quality and health outcomes for veterans with COPD. It also examines housing factors affecting COPD exacerbation, the use of low-cost sensors to monitor indoor pollution, and the cost-effectiveness of using air filters.See study design

What are the potential side effects?

Since this trial involves using an air cleaner rather than medication or invasive procedures, there are no direct side effects expected from the intervention itself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COPD exacerbations

Secondary outcome measures

6MWD

ED visits

Health related quality of life

+4 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: InterventionActive Control1 Intervention

an air cleaner with HEPA and carbon filter installed

Group II: PlaceboPlacebo Group1 Intervention

an air cleaner with the primary filter removed

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

ElevateUNKNOWN

1 Previous Clinical Trials

51 Total Patients Enrolled

Jesse Brown VA Medical CenterFED

7 Previous Clinical Trials

1,835 Total Patients Enrolled

US Department of Housing and Urban DevelopmentFED

7 Previous Clinical Trials

5,887 Total Patients Enrolled

Media Library

Air cleaner (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05913765 — N/A

Chronic Obstructive Pulmonary Disease Research Study Groups: Intervention, Placebo

Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Air cleaner Highlights & Side Effects. Trial Name: NCT05913765 — N/A

Air cleaner (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05913765 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant capacity of this clinical research endeavor?

"Yes, the available information on clinicaltrials.gov confirms that this medical trial is still open for recruitment. It was first published on November 1st 2023 and recently updated in June 13th of the same year. The research seeks to enroll 80 participants from a single location."

Answered by AI

Are there any vacancies available for individuals to participate in this clinical trial?

"Data on clinicaltrials.gov reveals that recruitment for this trial is still underway, with the initial advertisement posted on 11th January 2023 and last updated 13th June 2023."

Answered by AI